| Histopathological classification |
14F7 Mab reactivity |
Positive cases (%) |
| F-score |
| Low |
High |
| Breast cancer |
|
|
|
| Infiltrating lobular carcinoma |
7 |
4 |
15.9 |
| Infiltrating ductal carcinoma |
|
|
|
| No otherwise specified (NOS) |
2 |
13 |
86.7 |
| Other subtype minor represented |
6 |
14 |
70.0 |
| Total |
15 |
31 |
67.4 |
| Urinary bladder tumors |
|
|
|
| Urothelial cell carcinoma |
|
|
|
| Grade I |
4 |
7 |
63.6 |
| Grade II |
2 |
7 |
77.8 |
| Grade III |
2 |
31 |
93.9 |
| Squamous cell carcinoma |
0 |
1 |
100 |
| Undifferentiated tumor |
1 |
0 |
0 |
| Total |
9 |
46 |
83.6 |
| Malignant gliomas |
|
|
|
| Astrocytomas |
|
|
|
| Grade I |
4 |
0 |
0.0 |
| Grade II |
5 |
1 |
16.7 |
| Grade III |
9 |
4 |
30.8 |
| Grade IV |
5 |
7 |
58.3 |
| Other low-grade gliomas |
16 |
3 |
15.8 |
| Total |
39 |
15 |
27.8 |
| Legend. %, percentage; F-score: Low expression of NeuGcGM3 (F-score<150); High expression of NeuGcGM3 (F-score ≥ 150). |
